Pain Management Therapeutics Market Research Report by Indication (Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, and Migraine), by Therapeutics (Anesthetics, Anticonvulsants, Antidepressants, Antimigraine Agents, and Non-narcotic Analgesics), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market...
Cannabinoids as an ingredient for use in pharmaceuticals, F&B and other industries is steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations.With many technology developers focusing on overcoming...
The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding...
Cancer Pain - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Pipeline Review, H2 2020, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape. Cancer pain can be defined as a complex sensation that reflects...
The Europe gastrointestinal drugs market is expected to reach US$ 17,810.81 million by 2027 from US$ 12,721.85 million in 2019; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market. However, factors...
Market Introduction Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain.Neurovascular disorders lead to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis,...
The South and Central America pain management devices market is expected to reach US$ 477.32 million by 2027 from US$ 276.75 million in 2019. The market is anticipated to grow with a CAGR of 7.1% from 2020 to 2027. The South and Central America pain management devices market is expected to grow due to rising incidence of chronic pain and...
LATAM Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute...
Nociceptin Receptor - Pipeline Review, H2 2020 Summary According to the recently published report ’Nociceptin Receptor - Pipeline Review, H2 2020’; Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline Target constitutes close to 17 molecules. Out of...
Analgesics Global Market Report 2020-30: Covid 19 Implications and Growth covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for analgesics due to COVID 19. Description: Where...